NCT04916314

Brief Summary

Excess adiposity is a key causal factor in developing type 2 diabetes and weight loss improves glycaemia and can put diabetes in to remission. There is evidence that low carbohydrate diets also reduce glycaemia. The aim of this trial is to test a behavioural support programme delivered remotely to reduce energy intake and carbohydrate intake in particular to improve glycaemic control in people recently diagnosed with type 2 diabetes. We will recruit participants from general practice diabetes registers who were diagnosed within the past six years and who want to and are able to follow an app-based behavioural support programme to change their diet and have a BMI of at least 27kg/m2 (≥30kg/m2 if of white European ethnicity). They will be individually randomised 1:1 using simple randomisation to either intervention or a no-intervention control. Blinding of participants or their clinicians is impossible. The intervention comprises a 12-week behavioural support programme delivered by app or web, which provides group-based peer support, recipes for food providing low energy meals that are low in carbohydrate. The programme is delivered by a commercial company who run NHS commissioned programmes in several areas of the UK. Clinicians will adjust medication for hypertension and diabetes as needed. The co-primary outcomes are change in participants' HbA1c from baseline to 3 months and baseline to 1 year, with p-value adjustment to reflect multiple testing. The secondary outcomes are remission from diabetes, weight change, change in cardiovascular risk factors, and change in quality of life at 3 months and 1 year. The trial will assess whether this app-based programme improves outcomes for people with type 2 diabetes relative to usual care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
115

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 26, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 7, 2021

Completed
24 days until next milestone

Study Start

First participant enrolled

July 1, 2021

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2023

Completed
2.3 years until next milestone

Results Posted

Study results publicly available

January 5, 2026

Completed
Last Updated

January 5, 2026

Status Verified

February 1, 2025

Enrollment Period

2.3 years

First QC Date

May 26, 2021

Results QC Date

November 14, 2025

Last Update Submit

December 11, 2025

Conditions

Keywords

DietLow-CarbohydrateDigital Intervention

Outcome Measures

Primary Outcomes (2)

  • Change From Baseline in Participants' HbA1c

    Change in participants' HbA1c from baseline to 3 months

    Baseline to 3 months

  • Change From Baseline in Participants' HbA1c

    Change in participants' HbA1c from baseline to 12 months

    Baseline to 12 months

Secondary Outcomes (11)

  • Diabetes Remission at 12 Months

    1 year

  • Weight Change From Baseline

    3 months,1 year

  • Change in Systolic Blood Pressure, From Baseline

    3 months, 1 year

  • Change in Diastolic Blood Pressure, From Baseline

    3 months, 1 year

  • Change in LDL Cholesterol From Baseline

    3 months, 1 year

  • +6 more secondary outcomes

Other Outcomes (5)

  • Dietary Intake Patterns

    Baseline, 3 months, 1 year

  • Engagement With Programme; 'Learn' Component of the Programme

    Baseline, 3 months, 1 year

  • Engagement With Programme; 'Track' Component of the Programme

    Baseline, 3 months, 1 year

  • +2 more other outcomes

Study Arms (2)

Low Carbohydrate Diet

EXPERIMENTAL

. The intervention involves diet, activity and behaviour change components. It comprises a three-month remote behavioural change programme with mentoring from a registered dietitian or nutritionist (health coach), peer group support, structured education articles and activity tracking technology. These elements are accessed via a smartphone or web-based application. Each participant will also receive a hard copy of an instructional handbook and a recipe book.

Behavioral: Low Carbohydrate diet

Standard NHS type 2 diabetes care

NO INTERVENTION

Participants randomised to the control group will receive no additional intervention, and will continue to receive their usual NHS diabetes care from their general practice.

Interventions

The intervention is a three-month remote behavioural change programme with mentoring from a registered dietitian or nutritionist (health coach), encouraging adoption of a low energy, low-carbohydrate diet, peer group support, structured education articles and activity tracking technology. These elements are accessed via a smartphone or web-based application; each participant additionally receives an instructional handbook, and recipe book (+/-wireless weighing and activity tracking technology).

Low Carbohydrate Diet

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participant is willing and able to give informed consent for participation in the study.
  • Male or Female, aged 40 years or above.
  • Diagnosed with current type 2 diabetes (i.e. not in remission) in the last 6 years
  • BMI of ≥27kg/m2 (≥30kg/m2 if ethnicity recorded as white)
  • Has a smartphone or computer with internet access (and the correct operating system requirements to use the intervention programme)
  • Are able to complete the eligibility and baseline assessments online
  • Would like to make changes to their diet or lifestyle to improve their diabetes control, lose weight, or improve their general health

You may not qualify if:

  • Unable to understand the study materials and interventions
  • Currently following a weight loss programme (defined as a structured, prescribed and monitored programme and not a self-directed weight loss attempt)
  • Pregnant, breastfeeding, or planning to become pregnant during the course of the study
  • History of bariatric surgery, including gastric banding
  • Currently using insulin therapy
  • Proliferative diabetic retinopathy, or maculopathy.
  • Recent myocardial infarction or stroke (\<3 months)
  • Renal failure (chronic kidney disease stage 4 or 5)
  • Current active treatment for cancer (other than skin cancer treated with curative intent by local treatment only)
  • Their doctor does not feel they are appropriate to participate for another reason (e.g. active eating disorder diagnosis, significant psychological disturbance)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Oxford

Warwick, Select A Region, CV34 4NH, United Kingdom

Location

Related Publications (1)

  • Morris E, Scragg J, Stevens R, Albury C, Aveyard P, Jebb SA. A randomised controlled trial of a low-carbohydrate digitally-supported weight loss programme for type 2 diabetes. NPJ Digit Med. 2025 Dec 2;8(1):739. doi: 10.1038/s41746-025-02116-w.

MeSH Terms

Interventions

Diet, Carbohydrate-Restricted

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Results Point of Contact

Title
Dr Elizabeth Morris
Organization
University of Oxford

Study Officials

  • Paul Aveyard, FRCP

    University of Oxford

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
The nature of the intervention means it is not possible to mask providers or patients
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 26, 2021

First Posted

June 7, 2021

Study Start

July 1, 2021

Primary Completion

October 1, 2023

Study Completion

October 1, 2023

Last Updated

January 5, 2026

Results First Posted

January 5, 2026

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

IPD will be available upon direct request to the study team

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
The data will be available indefinitely when the investigators have completed their analysis, about 1 year after final follow-up.
Access Criteria
Request is for bona fide reasons from an organisation whose mission is to benefit the public good.

Locations